Cusack Thomas - Insider Non-Derivative Transactions at HERON THERAPEUTICS, INC. /DE/ (HRTX) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 8, 2025, Cusack Thomas's relationship to HERON THERAPEUTICS, INC. /DE/ (HRTX) is Director, and currently has 37,879 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other HRTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Cusack Thomas - Insider Non-Derivative Transactions of HRTX Common Stock

Cusack Thomas - Insider Non-Derivative Transactions at HRTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 9, 2025	Acquisition -- (Common Stock)	37879	0	37879